Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Infection and hemostasis].

J Hudecek1, M Paceková, J Chudej

  • 1Klinika hematológie a transfuziológie JLF UK a MFN, Martin, Slovenská republika.

Vnitrni Lekarstvi
|September 7, 2004
PubMed
Summary

Sepsis can cause dangerous blood clotting by inhibiting natural clot breakdown. Natural coagulation inhibitors may treat this sepsis-induced coagulopathy without increasing bleeding risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study.

Journal of thrombosis and haemostasis : JTH·2018
Same author

[Thrombophilia in pregnacy].

Ceska gynekologie·2016
Same author

Activity of coagulation factor XI in patients with spontaneous miscarriage: the presence of risk alleles.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2014
Same author

Monitoring the efficacy of ADP inhibitor treatment in patients with acute STEMI post-PCI by VASP-P flow cytometry assay.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2014
Same author

[Five year-results of chemoresistance testing in cancer patients].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2012
Same author

Binding of proteins to ultra high molecular weight polyethylene wear particles as a possible mechanism of macrophage and lymphocyte activation.

Journal of biomedical materials research. Part A·2010

Area of Science:

  • Hematology
  • Immunology
  • Infectious Diseases

Context:

  • Sepsis involves a systemic inflammatory response that impacts hemostasis.
  • Disseminated intravascular coagulation (DIC) is a common, severe complication of sepsis, increasing mortality.
  • Infection progression can lead to cytokine-mediated activation of coagulation and fibrinolysis.

Purpose:

  • To explore the role of hemostasis dysregulation in sepsis.
  • To investigate the mechanisms behind hypercoagulation during sepsis, particularly the inhibition of fibrinolysis.
  • To evaluate the therapeutic potential of natural coagulation inhibitors for sepsis-induced coagulopathy.

Summary:

  • Sepsis triggers inflammation, activating coagulation and fibrinolysis pathways.
  • Overproduction of plasminogen activator inhibitor-1 (PAI-1) in later sepsis stages inhibits fibrinolysis, leading to hypercoagulation and DIC.
  • Microbial virulence factors can directly affect hemostasis.
  • Natural coagulation inhibitors possess both anticoagulation and anti-inflammatory properties.

Impact:

  • Natural coagulation inhibitors show promise as a treatment for sepsis-induced coagulopathy.
  • These inhibitors may mitigate hypercoagulation and DIC without a significant increase in bleeding risk.
  • Understanding hemostatic alterations in sepsis is crucial for improving patient outcomes.

Related Experiment Videos